D. Atallah
Institut Gustave Roussy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by D. Atallah.
Journal of The American College of Surgeons | 2003
Philippe Morice; Franklin Joulie; Sophie Camatte; D. Atallah; Roman Rouzier; Patricia Pautier; Christophe Pomel; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne
BACKGROUNDnThe purpose was to determine the factors influencing nodal involvement and topography of pelvic and paraaortic node involvement in ovarian carcinoma.nnnSTUDY DESIGNnBetween 1985 and 2001, 276 women with epithelial ovarian carcinoma underwent systematic bilateral pelvic and paraaortic lymphadenectomy.nnnRESULTSnThe overall frequency of lymph node involvement was 44% (122 of 276). The frequency of pelvic and paraaortic metastases were 30% (82 of 276) and 40% (122 of 276), respectively. The frequency of lymph node metastases according to the stage of the disease (stages I, II, and III + IV) were: 20% (17 of 85), 40% (6 of 15), and 55% (99 of 176), respectively. In patients with stage IA, IB, and IC disease, the rates of nodal involvement were 13% (8 of 60), 33% (4 of 12), and 38% (5 of 13), respectively. None of 15 patients with stage IA grade 1 disease had nodal involvement. None of the 20 patients with mucinous tumors confined to the ovary(ies) (stage I disease) had nodal involvement. When paraaortic nodes were involved, the left paraaortic chain above the level of the inferior mesenteric artery was the most frequently involved site (70 patients, 63%). One of nine patients (11%) with a macroscopic stage I unilateral tumor and paraaortic involvement had contralateral metastases.nnnCONCLUSIONSnLymphadenectomy should be performed even in patients with stage IA disease. This procedure could be omitted in patients with mucinous apparent stage I disease and stage I grade 1 tumor. Lymphadenectomy should involve the whole pelvic and paraaortic chain up to the level of the left renal vein. A bilateral dissection should be performed even in cases of patients with a unilateral tumor.
Journal of The American College of Surgeons | 2002
Jean-Pierre Lefranc; D. Atallah; Sophie Camatte; Jean Blondon
BACKGROUNDnThere are many surgical procedures to treat posthysterectomy vaginal vault prolapse. Abdominal sacral colpopexy is one of these procedures. The aim of this study was to review the cases of 85 consecutive patients treated by this technique since 1978 by the same surgical team using the same procedure. Our surgical procedure will be explained.nnnSTUDY DESIGNnEighty-five patients were treated in our department between 1978 and 1998 for posthysterectomy vaginal vault prolapse. The mean age was 55.42 years. The mean weight was 63.37 kg. Their parity ranged from 0 to 5 (mean, 2.54). The interval of time between hysterectomy and vaginal vault prolapse repair ranged from 1 to 37 years (mean, 17.92 years). The main indication for hysterectomy was uterine leiomyomas. Of these patients, 67.05% had stress urinary incontinence, and mean urethral closure pressure was 48.7 cm H2O. All patients had abdominal sacral colpopexy associated with a Burch procedure and a posterior perineal repair.nnnRESULTSnSeventeen patients had postoperative fever. Twenty-two had urinary tract infections. Two patients had to undergo blood transfusion. Three patients had postoperative urinary retention. The median longterm followup was 10.5 years; 27.05% of patients had relapsing stress urinary incontinence. Two patients had a relapse of the vaginal vault prolapse.nnnCONCLUSIONSnThe abdominal sacral colpopexy is a safe operation with low morbidity and long-standing good results. It can be recommended for sexually active women. Nevertheless, the Burch procedure performed with this operation failed to prevent recurrence of urinary incontinence.
Journal of The American College of Surgeons | 2002
Sophie Camatte; Philippe Morice; D. Atallah; Patricia Pautier; Catherine Lhommé; Christine Haie-Meder; Pierre Duvillard; Damienne Castaigne
BACKGROUNDnThe aim of this study is to evaluate the rate and the clinical outcomes of lymph node involvement in patients treated for borderline ovarian tumor (BOT).nnnSTUDY DESIGNnForty-two patients were treated for BOT with a procedure that included lymphadenectomy. Twenty-four patients underwent a pelvic lymphadenectomy, 6 a paraaortic lymphadenectomy, and 12 both procedures. Thirty-two patients underwent systematic lymphadenectomy, five because of associated cancer (uterine cervix or corpus) and five because of bulky nodes discovered during the surgical procedure.nnnRESULTSnAn endosalpingiosis was present in 11 (26%) patients who underwent lymphadenectomy. Eight patients had nodal involvement related to the BOT. All patients with nodal involvement had serous BOT with peritoneal implants. None of the patients with a mucinous tumor had nodal involvement. None of the patients with early-stage disease (without peritoneal disease) had nodal involvement discovered after routine lymphadenectomy. None of the patients with nodal involvement died of borderline tumor. One patient died of a complication of adjuvant therapy (leukemia after chemotherapy).nnnCONCLUSIONSnThe prognosis of patients with borderline tumors of the ovary and nodal involvement is excellent. Routine lymphadenectomy should not be performed in patients with early-stage disease. This procedure should be carried out in patients with serous tumor and enlarged lymph nodes.
Gynecologie Obstetrique & Fertilite | 2003
Philippe Morice; A Rodrigues; Patricia Pautier; Annie Rey; Sophie Camatte; D. Atallah; Christophe Pomel; Catherine Lhommé; Christine Haie-Meder; Pierre Duvillard; Damienne Castaigne
Hysterectomy and bilateral salpingo-oophorectomy is the gold standard for the surgical procedure of uterine sarcoma in case of tumor limited to the uterine corpus. Omentectomy and lymphadenectomy should be performed in carcinosarcoma. In others histologic subtypes, lymphadenectomy should be performed only in patients with enlarged nodes discovered at the time of the surgical procedure. Surgical resection should be ideally performed without uterine parcelling out and so using a laparotomy in order to avoid this risk.
Gynecologic Oncology | 2003
Christophe Pomel; D. Atallah; Guillaume Le Bouedec; Roman Rouzier; Philippe Morice; Damienne Castaigne; J. Dauplat
Annals of Oncology | 2003
Philippe Morice; Sophie Camatte; Annie Rey; D. Atallah; Catherine Lhommé; Patricia Pautier; C. Pomel; J.-F. Coté; Christine Haie-Meder; Pierre Duvillard; Damienne Castaigne
Journal of The American College of Surgeons | 2003
Philippe Morice; Gil Dubernard; Annie Rey; D. Atallah; Patricia Pautier; Christophe Pomel; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne
Annals of Oncology | 2003
Philippe Morice; D. Brehier-Ollive; Annie Rey; D. Atallah; Catherine Lhommé; Patricia Pautier; C. Pomel; Sophie Camatte; Pierre Duvillard; Damienne Castaigne
Annals of Oncology | 2004
Philippe Morice; C. Deyrolle; Annie Rey; D. Atallah; Patricia Pautier; Sophie Camatte; Anne Thoury; Catherine Lhommé; Christine Haie-Meder; Damienne Castaigne
Annals of Oncology | 2004
Sophie Camatte; Philippe Morice; D. Atallah; Anne Thoury; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne